Innovative Medicines Initiative launches translational safety biomarker pipeline project to enable development and implementation of novel safety biomarkers
Mönchengladbach, April 15, 2019 – The Innovative Medicines Initiative (IMI) today announced the launch of the Translational Safety Biomarker Pipeline (TransBioLine) Project, a five-year program to


